Wikidata

(Q40684788)

English

A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

scientific article published on September 2001

In more languages

Statements

title
A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
author name string
Cunningham CC
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Holmlund JT
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Geary RS
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Kwoh TJ
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Johnston JF
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Monia B
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
Nemunaitis J
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
publication date
1 September 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
page(s)
1265-1271
1 reference
stated in
Europe PubMed Central
PubMed ID
11571742
retrieved
22 September 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40684788&oldid=1904809445"